Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
Open Access
- 9 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1121540
Abstract
Background: Nonalcoholic Fatty Liver Disease(NAFLD)refers to a spectrum of diseases ranging from simple liver steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Bidirectional cross-talk between the gut-liver axis plays an important role in the pathogenesis of NAFLD. To learn more about the gut-liver axis in NAFLD, this study aims to provide a comprehensive analysis from a bibliometric perspective.Method: Literature related to the gut-liver axis in NAFLD from 1989 to 2022 was extracted from the Web of Science Core Collection. Based on Microsoft Excel, CiteSpace and Vosviewer, we conducted to analyze the number of publications, countries/regions, institutions, authors, journals, references, and keywords.Results: A total of 1,891 literature since 2004 was included, with the rapid growth of the number of papers on the gut-liver axis in NAFLD annually. These publications were mainly from 66 countries and 442 institutions. Of the 638 authors analyzed, Bernd Schnabl was the one with the most publications, and Patrice D. Cani was the one with the most co-citations. International Journal of Molecular Sciences is the journal with the most articles published, and Hepatology is the journal with the most citations. The most common keywords are gut microbiota, inflammation, and insulin instance, which are current research hotspots. Short-chain fatty acid, in vitro, randomized controlled trial in clinical, and diabetes mellitus represent the research frontiers in this field and are in a stage of rapid development.Conclusion: This is the first study to conduct a comprehensive bibliometric analysis of publications related to the gut-liver axis in NAFLD. This study reveals that gut microbiota, inflammation, insulin resistance, short-chain fatty acids, and randomized controlled trial will be the hotspots and new trends in the gut-liver axis in NAFLD research, which could provide researchers with key research information in this field and is helpful for further exploration of new research directions.Keywords
Funding Information
- National Natural Science Foundation of China (2019ZX09201004-001)
This publication has 81 references indexed in Scilit:
- Intestinal microbiota in patients with nonalcoholic fatty liver diseaseHepatology, 2013
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight lossGut, 2011
- Novel Evidence for Chronic Exposure to Endotoxin in Human Nonalcoholic SteatohepatitisJournal of Clinical Gastroenterology, 2011
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†Hepatology, 2009
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityGut, 2009
- Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxinJournal of Hepatology, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literatureJournal of the American Society for Information Science and Technology, 2005
- Searching for intellectual turning points: Progressive knowledge domain visualizationProceedings of the National Academy of Sciences, 2004